Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

NCT06790225 is registered in ClinicalTrials.gov with Esbjerg Hospital - University Hospital of Southern Denmark as lead sponsor.

NCT NCT06790225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Phase
Not applicable
Overall status
Completed
Start date
November 10, 2025
Completion date
September 17, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone disease, metabolic, diabetes mellitus, type 2, obesity and obesity-related medical conditions